erytech pharma

Clinical-stage biopharmaceutical company developing innovative therapies for rare cancers and orphan diseases.
Erytech was listed on the stock exchange in 2014.

heads

Gilles BEYEN

Eric SOYER

Iman EL-HARIRY

Jean-Sébastien CLEIFTIE